Terms: = Colorectal cancer AND CBFA2T3, ETO2, 863, ENSG00000129993, ZMYND4, MTGR2, MTG16 AND Treatment
33 results:
1. A nomogram for preoperative differentiation of tumor deposits from lymph node metastasis in rectal cancer: A retrospective study.
Jin Y; Wang Y; Zhu Y; Li W; Tang F; Liu S; Song B
Medicine (Baltimore); 2023 Oct; 102(41):e34865. PubMed ID: 37832071
[TBL] [Abstract] [Full Text] [Related]
2. Predictive value of infiltrating tumor border configuration of rectal cancer on MRI.
Lv B; Yuan L; Li J; Kong X; Cheng Y; Shang K; Jin E
BMC Med Imaging; 2023 Oct; 23(1):155. PubMed ID: 37828450
[TBL] [Abstract] [Full Text] [Related]
3. Improved stage and survival for patients in the Aotearoa New Zealand colorectal cancer screening program 2012-2019.
Al Hinai K; Fischer J; Al Mamari A; Hulme-Moir M
ANZ J Surg; 2023 Nov; 93(11):2669-2674. PubMed ID: 37287212
[TBL] [Abstract] [Full Text] [Related]
4. Impact of systemic cancer treatment on quality of life and mental well-being: a comparative analysis of patients with localized and advanced cancer.
Rodríguez-Gonzalez A; Carmona-Bayonas A; Hernandez San Gil R; Cruz-Castellanos P; Antoñanzas-Basa M; Lorente-Estelles D; Corral MJ; González-Moya M; Castillo-Trujillo OA; Esteban E; Jiménez-Fonseca P; Calderon C
Clin Transl Oncol; 2023 Dec; 25(12):3492-3500. PubMed ID: 37247131
[TBL] [Abstract] [Full Text] [Related]
5. Simultaneous versus staged major hepatectomy (≥3 liver segments) for outcomes of synchronous colorectal liver metastases: A systematic review and meta-analysis.
Liu J; Xia Y; Pan X; Yan Z; Zhang L; Yang Z; Wu Y; Xue H; Bai S; Shen F; Wang K
Cancer Rep (Hoboken); 2022 Aug; 5(8):e1617. PubMed ID: 35753719
[TBL] [Abstract] [Full Text] [Related]
6. Antiangiogenic Drug-Induced Proteinuria as a Prognostic Factor in Metastatic colorectal cancer.
Moisuc DC; Marinca MV; Gafton B; Alexa-Stratulat T; Pavel-Tanasa M; Cianga P
Curr Oncol; 2022 May; 29(6):3996-4011. PubMed ID: 35735428
[TBL] [Abstract] [Full Text] [Related]
7. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract] [Full Text] [Related]
8. Assessment of exposure-response relationship for bevacizumab in patients with metastatic colorectal cancer.
Peña-Cabia S; Royuela Vicente A; Ramos Díaz R; Gutiérrez Nicolás F; Peñalver Vera Á; Siso García I; Hitt Sabag R; García Lacalle C; Peña-Cabia A; Iglesias-Peinado I; García Díaz B; López-Martín A
Biomed Pharmacother; 2021 Sep; 141():111827. PubMed ID: 34153845
[TBL] [Abstract] [Full Text] [Related]
9. Relationship between metformin therapy and risk of colorectal cancer in patients with diabetes mellitus: a meta-analysis.
Yang WT; Yang HJ; Zhou JG; Liu JL
Int J Colorectal Dis; 2020 Nov; 35(11):2117-2131. PubMed ID: 32720184
[TBL] [Abstract] [Full Text] [Related]
10. High MICB expression as a biomarker for good prognosis of colorectal cancer.
Feng Q; Yu S; Mao Y; Ji M; Wei Y; He G; Chang W; Zhu D; Ren L; Xu J
J Cancer Res Clin Oncol; 2020 Jun; 146(6):1405-1413. PubMed ID: 32306128
[TBL] [Abstract] [Full Text] [Related]
11. Predictive Value of [
Kim SH; Song BI; Kim BW; Kim HW; Won KS; Bae SU; Jeong WK; Baek SK
Sci Rep; 2019 Mar; 9(1):4979. PubMed ID: 30899056
[TBL] [Abstract] [Full Text] [Related]
12. Kaiso is required for mtg16-dependent effects on colitis-associated carcinoma.
Short SP; Barrett CW; Stengel KR; Revetta FL; Choksi YA; Coburn LA; Lintel MK; McDonough EM; Washington MK; Wilson KT; Prokhortchouk E; Chen X; Hiebert SW; Reynolds AB; Williams CS
Oncogene; 2019 Jun; 38(25):5091-5106. PubMed ID: 30858547
[TBL] [Abstract] [Full Text] [Related]
13. Time to initial cancer treatment in the United States and association with survival over time: An observational study.
Khorana AA; Tullio K; Elson P; Pennell NA; Grobmyer SR; Kalady MF; Raymond D; Abraham J; Klein EA; Walsh RM; Monteleone EE; Wei W; Hobbs B; Bolwell BJ
PLoS One; 2019; 14(3):e0213209. PubMed ID: 30822350
[TBL] [Abstract] [Full Text] [Related]
14. When does curatively treated colorectal cancer recur? An Australian perspective.
Reece MM; Chapuis PH; Keshava A; Stewart P; Suen M; Rickard MJFX
ANZ J Surg; 2018 Nov; 88(11):1163-1167. PubMed ID: 30277301
[TBL] [Abstract] [Full Text] [Related]
15. Estimation of Future cancer Burden Among Rescue and Recovery Workers Exposed to the World Trade Center Disaster.
Singh A; Zeig-Owens R; Moir W; Hall CB; Schwartz T; Vossbrinck M; Jaber N; Webber MP; Kelly KJ; Ortiz V; Koffler E; Prezant DJ
JAMA Oncol; 2018 Jun; 4(6):828-831. PubMed ID: 29710126
[TBL] [Abstract] [Full Text] [Related]
16. Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer.
Herbst A; Vdovin N; Gacesa S; Ofner A; Philipp A; Nagel D; Holdt LM; Op den Winkel M; Heinemann V; Stieber P; Graeven U; Reinacher-Schick A; Arnold D; Ricard I; Mansmann U; Hegewisch-Becker S; Kolligs FT
Int J Cancer; 2017 May; 140(9):2134-2144. PubMed ID: 28124380
[TBL] [Abstract] [Full Text] [Related]
17. Predictive value of mucinous histology in colon cancer: a population-based, propensity score matched analysis.
Warschkow R; Tarantino I; Huttner FJ; Schmied BM; Guller U; Diener MK; Ulrich A
Br J Cancer; 2016 Apr; 114(9):1027-32. PubMed ID: 26977857
[TBL] [Abstract] [Full Text] [Related]
18. 18F-FDG PET/CT Is an Immediate Imaging Biomarker of treatment Success After Liver Metastasis Ablation.
Cornelis F; Sotirchos V; Violari E; Sofocleous CT; Schoder H; Durack JC; Siegelbaum RH; Maybody M; Humm J; Solomon SB
J Nucl Med; 2016 Jul; 57(7):1052-7. PubMed ID: 26912433
[TBL] [Abstract] [Full Text] [Related]
19. Variations in Metastasis Site by Primary Location in Colon cancer.
Amri R; Bordeianou LG; Sylla P; Berger DL
J Gastrointest Surg; 2015 Aug; 19(8):1522-7. PubMed ID: 25933582
[TBL] [Abstract] [Full Text] [Related]
20. Quality-adjusted cost of care: a meaningful way to measure growth in innovation cost versus the value of health gains.
Lakdawalla D; Shafrin J; Lucarelli C; Nicholson S; Khan ZM; Philipson TJ
Health Aff (Millwood); 2015 Apr; 34(4):555-61. PubMed ID: 25847636
[TBL] [Abstract] [Full Text] [Related]
[Next]
